Abstract
The continuing high incidence of vascular disease is leading to a greater need for interventional therapies and vascular prostheses. Nitric oxide (NO), which has been heavily investigated in recent years as an important biological mediator, is presented in this work as a sustained localized therapeutic for vascular disorders, specifically in the prevention of restenosis. NO-releasing PEG hydrogels were applied to the outer surfaces of carotid arteries following balloon denudation in a rat animal model. NO was allowed to diffuse into the vessel, and intimal thickening, as assessed after 2 and 28 days, was almost fully eliminated, showing an approximate 90% decrease. Meanwhile, endothelial cell migration and proliferation into the damaged vessel sections were observed. These results signify that these materials are suitable to prevent intimal hyperplasia and induce endothelialization in vivo, making these NO-releasing hydrogels an ideal candidate for incorporation into blood-contacting devices for the prevention of restenosis.
Similar content being viewed by others
References
Agata, J., J. J. Zhang, J. Chao, and L. Chao. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regul. Pept. 112:115–120, 2003.
Bailey, S. R. Local drug delivery: current applications. Prog. Cardiovasc. Dis. 40:183–204, 1997.
Bauters, C., and J. M. Isner. The biology of restenosis. Prog. Cardiovasc. Dis. 40(2):107–116, 1997.
Bohl, K. S., and J. L. West. Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. Biomaterials 21:2273–2278, 2000.
Bult, H. Restenosis: a challenge for pharmacology. Trends Pharmacol. Sci. 21(7):274–279, 2000.
Dangas, G. D., B. E. Claessen, A. Caixeta, E. A. Sanidas, G. S. Mintz, and R. Mehran. In-stent restenosis in the drug-eluting stent era. J. Am. Coll. Cardiol. 56:1897–1907, 2010.
Elkins, C. J., J. M. Waugh, P. G. Amabile, H. Minamiguchi, M. Uy, K. Sugimoto, et al. Development of a platform to evaluate and limit in-stent restenosis. Tissue Eng. 8:395–407, 2002.
Ettenson, D. S., and E. R. Edelman. Local drug delivery: an emerging approach in the treatment of restenosis. Vasc. Med. 5:97–102, 2000.
Fattori, R., and T. Piva. Drug-eluting stents in vascular intervention. Lancet 361:247–249, 2003.
Folts, J. D., and J. Loscalzo. Coating arterial and blood-contacting surfaces with NO-donating materials. In: Nitric Oxide and the Cardiovascular System, edited by J. Loscalzo, and J. A. Vita. Totowa, NJ: Humana Press, 2000, pp. 503–514.
Herrmann, R., G. Schmidmaier, B. Markl, A. Resch, I. Hahnel, A. Stemberger, et al. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb. Haemost. 82:51–57, 1999.
Hrabie, J. A., J. R. Klose, D. A. Wink, and L. K. Keefer. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 58:1472–1476, 1993.
Jun, H. W., L. J. Taite, and J. L. West. Nitric oxide-producing polyurethanes. Biomacromolecules 6:838–844, 2005.
Kapadia, M. R., L. W. Chow, N. D. Tsihlis, S. S. Ahanchi, J. W. Eng, J. Murar, et al. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J. Vasc. Surg. 47:173–182, 2008.
Kavanagh, C. A., Y. A. Rochev, W. M. Gallagher, K. A. Dawson, and A. K. Keenan. Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems. Pharmacol. Ther. 102:1–15, 2004.
Keefer, L. K. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu. Rev. Pharmacol. Toxicol. 43:585–607, 2003.
Kelm, M. Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta 1411:273–289, 1999.
Lee, M. S., E. M. David, R. R. Makkar, and J. R. Wilentz. Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation-fibrinolysis system. J. Pathol. 203:861–870, 2004.
Lipke, E. A., and J. L. West. Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model. Acta Biomater. 1(6):597–606, 2005.
Majesky, M. W., C. M. Giachelli, M. A. Reidy, and S. M. Schwartz. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. Circ. Res. 71:759–768, 1992.
Masters, K. S., E. A. Lipke, E. E. Rice, M. S. Liel, H. A. Myler, C. Zygourakis, et al. Nitric oxide-generating hydrogels inhibit neointima formation. J. Biomater. Sci. Polym. Ed. 16:659–672, 2005.
Moore, S. Amino acid analysis: aqueous dimethyl sulfoxide as solvent for the ninhydrin reaction. J. Biol. Chem. 243:6281–6283, 1968.
Pearce, C. G., S. F. Najjar, M. R. Kapadia, J. Murar, J. Eng, B. Lyle, et al. Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Free Radic. Biol. Med. 44:73–81, 2008.
Raman, V. K., and E. R. Edelman. Coated stents: local pharmacology. Semin. Interv. Cardiol. 3:133–137, 1998.
Saavedra, J. E., D. L. Mooradian, K. A. Mowery, M. H. Schoenfisch, M. L. Citro, K. M. Davies, et al. Conversion of a polysaccharide to nitric oxide-releasing form. Dual-mechanism anticoagulant activity of diazeniumdiolated heparin. Bioorg. Med. Chem. Lett. 10(8):751–753, 2000.
Sharma, S., C. Christopoulos, N. Kukreja, and D. A. Gorog. Local drug delivery for percutaneous coronary intervention. Pharmacol. Ther. 2010
Taite, L. J., P. Yang, H. W. Jun, and J. L. West. Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J. Biomed. Mater. Res. B Appl. Biomater. 84(1):108–116, 2008.
Takamiya, Y., S. I. Miura, Y. Tsuchiya, Y. Fukuda, B. Zhang, T. Kuwano, et al. Angiographic late lumen loss at the site of overlap of multiple Cypher sirolimus-eluting stents: ALSOCE study. J. Cardiol. 2010
Tanabe, K., E. Regar, C. H. Lee, A. Hoye, W. J. van der Giessen, and P. W. Serruys. Local drug delivery using coated stents: new developments and future perspectives. Curr. Pharm. Des. 10:357–367, 2004.
Virmani, R., F. D. Kolodgie, A. Farb, and A. Lafont. Drug eluting stents: are human and animal studies comparable? Heart 89:133–138, 2003.
Walter, D. H., M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, P. W. Stratford, et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 110:36–45, 2004.
West, J. L., and J. A. Hubbell. Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing. Proc. Natl Acad. Sci. U.S.A. 93:13188–13193, 1996.
Acknowledgments
Research funding was provided by an NSF CAREER Award [BES-9875607], the Rice University Alliance for Graduate Education and the Professoriate (AGEP) [NSF Cooperative Agreement No. [HRD-9817555], and the Rice University Integrative Graduate Education and Research Traineeship [NSF IGERT Grant 0114264].
Conflicts of interest
No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Adrian Chester oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Taite, L.J., West, J.L. Sustained Delivery of Nitric Oxide from Poly(ethylene glycol) Hydrogels Enhances Endothelialization in a Rat Carotid Balloon Injury Model. Cardiovasc Eng Tech 2, 113–123 (2011). https://doi.org/10.1007/s13239-011-0040-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13239-011-0040-z